Valo Health will focus its efforts on using Opal to "discover new therapeutic targets in real-world data, validate those targets in human-centric models, and develop new medicines with [its] AI ...

(Reuters) - Danish drugmaker Novo Nordisk and U.S. tech firm Valo Health said on Wednesday they ... using human data and artificial intelligence (AI). WHY IT'S IMPORTANT Last month Novo's drug ...

Valo Health’s Rho kinase (ROCK ... Novo Nordisk pays $60M for 3 preclinical assets as part of AI-powered cardio collab with Valo “While the data were intrigu­ing, OPL-0401 did not incor ...

has been acquired by Valo Health, a drug discovery and development platform that leverages AI-powered computation and data. “TARA’s proprietary human cardiac disease platform enables Valo to advance ...

Novo Nordisk and Valo Health have expanded their agreement to discover and develop new treatments for type 2 diabetes, ...

Lexington: Novo Nordisk A/S and Valo Health, Inc. have announced they have entered into an expanded agreement to discover and develop novel treatments for obesity, type 2 diabetes, ...

In September, for example, the company signed an agreement with US start-up Valo Health to apply its AI-powered drug discovery engine to find new therapies for cardiometabolic diseases ...

Novo Nordisk has expanded its partnership with Valo Health to advance new therapies for type 2 diabetes, obesity and ...

Novo Nordisk NOVO.B2.14%increase; green up pointing triangle expanded a deal with Valo Health to discover and develop treatments for obesity, type 2 diabetes and cardiovascular disease using human ...